Drugs Information: Ipilimumab
Basic Information
|
||
| ID | DDInter969 | |
| Drug Type | biotech | |
| Molecular Formula | C6572H10126N1734O2080S40 | |
| Molecular Weight | - | |
| Description | Ipilimumab is a human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. | |
| ATC Classification | L01XC11 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Ipilimumab
| Severity level | ID | Name | Mechanism | Detail |
|---|